-
1 Comment
Tiansheng Pharmaceutical Group Co., Ltd is currently in a long term uptrend where the price is trading 15.5% above its 200 day moving average.
From a valuation standpoint, the stock is 88.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.1.
Tiansheng Pharmaceutical Group Co., Ltd's total revenue sank by 25.3% to $290M since the same quarter in the previous year.
Its net income has increased by 26.9% to $-51M since the same quarter in the previous year.
Finally, its free cash flow grew by 170.6% to $37M since the same quarter in the previous year.
Based on the above factors, Tiansheng Pharmaceutical Group Co., Ltd gets an overall score of 4/5.
| Industry | Biotechnology |
|---|---|
| Sector | Healthcare |
| ISIN | CNE100002QC3 |
| CurrencyCode | CNY |
| Exchange | SHE |
| Beta | 0.31 |
|---|---|
| Market Cap | 2B |
| Dividend Yield | 0.0% |
| Target Price | None |
| PE Ratio | None |
Tiansheng Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing and circulation activities. It offers products in various categories, including respiratory, digestive, cardiovascular and cerebrovascular, pediatric, gynecological, orthopedic, tumor, hepatobiliary, blood, surgery, diabetes, and others. The company was founded in 2001 and is based in Chongqing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002872.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
